The Effects of Using the Web-Based Double Eye Control Program on Medication Error

NCT06371690 | Completed

• 1 other identifier: 17-11/37
• Study Type: observational
• Target: 1,070
• Locations: 1 country
• Sites: 1

Brief Summary

Methods: The study was carried out as a quasi-experimental study in the Pediatric Surgery Clinics of a university hospital using the "Pre-Test-Post-Test Model in a Single Group". The sample of the study consisted of all high-risk drugs administered by 24 nurses working in these clinics, taking part in medication and agreeing to take part in the study. Data were collected by the researcher using the Medication Observation Form. The Form was created based on the literature, and by making use of the "10 Correct Rules in Medication" and the Medication Skills Steps in the Double Eye Control Program. In the first step, medication error rates were determined through observation method. In the second step; the Web-Based Double-Eye Control Program, which is a standard drug dose calculation and medication program created by the researchers, was started to be implemented. Medication error rates were determined again through post-intervention observation method. Informed voluntary consent, ethics committee and hospital permissions were obtained for the implementation of the study.

Conditions

Main Heading (Descriptor) Terms

Keywords

Child; Child Nursing; High-Risk Drugs; Medication Error; Error Prevention Strategies

Outcome Measures

Primary Outcomes (1)

• Error rates

  Medication errors during administration of high-risk drugs in pediatric patients

  Between January 2017 and September 2018

Study Arms (1)

Medication errors during the application of high-risk drugs

Medication Errors During the Application of High-risk Drugs Before and After Using Web-Based Double-Eye Control Program

Other: Web-Based Double-Eye Control Program

Interventions

Web-Based Double-Eye Control Program OTHER

Web-Based Double-Eye Control Program, a web-based drug dose calculation program, is compatible with smartphones, tablets and computers. On the interface of the website, the nurse is required to enter data such as the age, weight, medications and doses ordered by the physician of the patient. When all these data are entered, the amount of medication that the nurse should give and whether the ordered dose is within the safe dose range for the patient are calculated by the program, so that the nurse can control her own calculations. On the other interface of the website, there are medication instructions uploaded by the researchers. With this interface, nurses access all pharmacological information about especially high-risk drugs (indications, contraindications, interacting drugs and fluids, fluids to be used for diluting, medication route, medication pace, etc.) and information that will enable the medication to be carried out in a standard way.

Medication errors during the application of high-risk drugs

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The population of the research was composed of Nurses working in the Pediatric Surgery Department Clinic (Pediatric Surgery, Pediatric Surgery Intensive Care, Neonatal Surgery Intensive Care Clinics) of a university hospital in Turkey between November 2017 and June 2018, and all high-risk drugs they administered.

You may qualify if:

• The medications observed were to be in the high-risk drug group for children,
• Volunteering of nurses working in the clinic to participate in the research,
• Nurses working in the clinic should have had proper level of internet usage knowledge to use a web-based program.

Sponsors & Collaborators

• Izmir Katip Celebi University: lead
• Ege University: collaborator

Study Sites (1)

Izmir Katip Celebi University

Izmir, Çi̇ğli̇, 35620, Turkey (Türkiye)

Location

Study Design

• Study Type: observational
• Observational Model: CASE CROSSOVER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor Doctor

Study Record Dates

• First Submitted: December 30, 2023
• First Posted: April 17, 2024
• Study Start: November 1, 2017
• Primary Completion: June 30, 2018
• Study Completion: September 30, 2018
• Last Updated: April 17, 2024

Record last verified: 2024-04

Locations

TU (1)